Figure 6: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for men in various BMI groups compared to patients in the “normal BMI”

Slides:

Advertisements

Similar presentations

1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.

Advertisements

Coronary heart disease (CHD) event rates in secondary prevention and acute coronary syndrome trials A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125.

© NOO 2011 noo National Obesity Observatory Examining available data for the adult population.

© NOO 2012 noo National Obesity Observatory Examining available data for the adult population.

analysis from the SHIFT study

Simple Noninvasive Systems Predict long-term Outcome of Patients With NAFLD Angulo P, Bugianesi E, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Barrera.

Obesity. Statistics 60% of U.S. population are overweight This figure has doubled since $75 billion spent per year due to obesity 100, ,000.

Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP

HDL LowLess than 40 mg/dL High60 mg/dL and above LDL OptimalLess than 100 mg/dL Near Optimal mg/dL Borderline High mg/dL High mg/dL.

Normal Distribution.

The ACTIVE Investigators. N Engl J Med 2009 Apr 3 [Epub]

The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. N Engl J Med 2006; available at: End pointActive therapy PlaceboRelative.

Shalev V, et al. Arch Intern Med 2009; 169:

Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:

Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate.

Supplementary Appendix Thrombotic Risk Scores % of Patients Risk Categories Low Risk (n=3491) Intermediate Risk (n=2806)

ACCORD Microvascular Outcomes

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Non-valvular Atrial Fibrillation.

Ann Intern Med. 2016;164(8): doi: /M Figure Legend:

Copyright © 2003 American Medical Association. All rights reserved.

Supplementary Table 1 Independent Predictors of 2-Year Mortality

Copyright © 2003 American Medical Association. All rights reserved.

Figure 2. A consort diagram showing the flowchart of the trial

Additional Figure 1: Hazard ratios of ER-positive and ER-negative tumors for increased BMI across 5-year age-bands. All models are for a 5 kg/m2 increase.

The relation between venous and arterial thrombosis

Supplementary material

The Effect of Smoking on the Risk of Sciatica: A Meta-analysis

Figure 1 Effects of childhood school grades, education, and work complexity on risk of dementia. Age- and gender-adjusted hazard ratios and 95% confidence.

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,

Bonnie Sanderson, PhD, RN

Odds Ratio with 95%-confidence interval

Nat. Rev. Cardiol. doi: /nrcardio

TNT Study: Baseline Characteristics of the Patients

Panelists. Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?

chemotherapy for patients with MC versus those with AC

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

A B Yeom Supplementary Fig.2

Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity Bjarne M. Nes, PhD, Christian R.

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased Fiona D.M. van Schaik, Martijn G.H.

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Molly E. Waring, PhD, Jane S

Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.

American Journal of Kidney Diseases

Visceral fat area (VFA, cm2), subcutaneous fat area (SFA, cm2), body mass index (BMI, kg/m2) and waist circumference (WC, cm) levels according to the quartiles.

Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis George Thomas, MD, MPH, Ethan M. Balk, MD,

Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries British Journal of Anaesthesia

Svend A. Mortensen et al. JCHF 2014;2:

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Volume 7, Issue 7, Pages (July 2010)

Figure 1 Comparison of MITRA-FR and COAPT trial outcomes

Beyond Body Mass Index: Advantages of Abdominal Measurements for Recognizing Cardiometabolic Disorders Henry S. Kahn, MD, Kai McKeever Bullard, PhD

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Comparison of Baseline Characteristics by Primary End Point

Serum resistin levels in women with polycystic ovary syndrome

Francesco Zaccardi, MD, PhD, Melanie J

Davide Capodanno et al. JCIN 2009;2:

Additional Figure 1: Hazard ratios of ER-positive and ER-negative tumors for increased BMI across 5-year age-bands. All models are for a 5 kg/m2 increase.

Prevalence of high SAT or high VAT by BMI category in women (A) and men (B) and by waist circumference category in women (C) and men (D). Prevalence of.

Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.

Baseline Q Waves and Time From Symptom Onset to ST-segment Elevation Myocardial Infarction: Insights From PLATO on the Influence of Sex Naji Kholaif,

This pooled data from 11 prospective cohort studies with 650,386 white adults found a significant correlation in all-cause mortality when waist circumference.

Increase of physical activity over time associated with lower HF risk

Additional Figure 2: Hazard ratios of PR+ and PR- tumors for increased BMI across 5-year age-bands. All models are for a 5 kg/m2 increase in BMI and were.

Outcomes Group Number of events Total person-years aIRR (95%CI)

Outcomes Number of events† Total person-years† aHR‡ (95%CI)

Outcomes Number of events† Total person-years† aHR‡ (95%CI)

Meta-analysis of trials examining the effects of aspirin on risk of CVD events in patients with diabetes. Meta-analysis of trials examining the effects.

Presentation transcript:

Figure 6: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for men in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementary data files A Hazard Ratios 95% CI

Figure 6: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for men in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementary data files B Hazard Ratios 95% CI

Figure 7: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for women in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementary data files A Hazard Ratios 95% CI

Figure 7: Risks of outcomes in the primary (C) and secondary (B) prevention cohorts for women in various BMI groups compared to patients in the “normal BMI” group. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementary data files B Hazard Ratios 95% CI

Figure 8: Risks of outcomes in the secondary prevention cohort for patients in five quintiles (Q) of waist circumference (WC) compared to patients in the 2 nd quintile of WC. The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. Supplementary data files ‘’ Hazard Ratios 95% CI ‘’

Figure 9: Risks of outcomes in the secondary prevention cohort for patients with optimal therapy (A) and suboptimal therapy (B) in five quintiles (Q) of waist circumference (WC) compared to patients in the reference group (quintile 2). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. A Supplementary data files Hazard Ratios 95% CI ‘’

Figure 9: Risks of outcomes in the secondary prevention cohort for patients with optimal therapy (A) and suboptimal therapy (B) in five quintiles (Q) of waist circumference (WC) compared to patients in the reference group (quintile 2). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. B Supplementary data files ‘’ Hazard Ratios 95% CI

Figure 10: Risks of outcomes in the secondary prevention cohort for men with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementary data files A Hazard Ratios 95% CI

Figure 10: Risks of outcomes in the secondary prevention cohort for men with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementary data files B Hazard Ratios 95% CI

Figure 11: Risks of outcomes in the secondary prevention cohort for women with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementary data files A Hazard Ratios 95% CI

Figure 11: Risks of outcomes in the secondary prevention cohort for women with optimal therapy (A) and suboptimal therapy (B) in various BMI groups compared to patients in the reference group (18 kg/m²<BMI<25 kg/m²). The hazard ratios and 95% confidence intervals are displayed on a logarithmic scale. ‘’ Supplementarry data files B Favor other BMI Favor BMI Hazard Ratios 95% CI